Aldeyra Therapeutics Inc. (ALDX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Aldeyra Therapeutics Inc.

NASDAQ: ALDX · Real-Time Price · USD
5.07
0.12 (2.42%)
At close: Sep 26, 2025, 3:59 PM
5.06
-0.20%
After-hours: Sep 26, 2025, 06:27 PM EDT

Aldeyra Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
54.53M 142.82M 144.42M 229.79M
Short-Term Investments
46.62M n/a 29.88M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
267.26K n/a n/a n/a
Receivables
n/a n/a 3.24M 28.77K
Inventory
n/a n/a n/a n/a
Other Current Assets
2.51M 4.65M 3.05M 2.5M
Total Current Assets
104.07M 147.81M 181.02M 232.75M
Property-Plant & Equipment
266.95K 516.58K 268.54K 384.35K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
534.22K 516.58K 268.54K 384.35K
Total Assets
104.61M 148.33M 181.29M 233.14M
Account Payables
180.45K 1.34M 133.63K 1.02M
Deferred Revenue
6M n/a n/a n/a
Short-Term Debt
31.37K 15.15M 911.76K n/a
Other Current Liabilities
4.33M 3.09M 3.82M 1.51M
Total Current Liabilities
18.6M 22.26M 15.36M 11.77M
Long-Term Debt
15M n/a 14.92M 15.5M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
15M 6.27M 14.92M 15.63M
Total Liabilities
33.6M 28.53M 30.28M 27.4M
Total Debt
15.3M 15.66M 16.08M 15.86M
Book Value
71M 119.8M 151.01M 205.74M
Book Value Per Share
1.19 2.03 2.59 3.81
Common Stock
59.65K 59.2K 58.56K 58.08K
Retained Earnings
-450.11M -394.26M -356.72M -294.69M
Comprehensive Income
37.44K n/a -103.94K n/a
Shareholders Equity
71M 119.8M 151.01M 205.74M
Total Investments
46.62M n/a 29.88M n/a